WOMEN METABOLIC DISORDERS DEPENDING ON THE DURATION OF MENOPAUSE

M.A. Tadjieva

doi:10.5281/zenodo.7684367

M.A. Tadjieva

Abstract. In recent years, much attention has been paid to the health of women in the climacteric period of life, since this period makes up almost a third of women. In this regard, the period of not only this health of a woman, but also her ability to work, the possibility of implementing various functions depends on the nature and manifestation. The study involved 75 women aged 45 to 60 years, who were divided into groups depending on the duration of menopause. According to the results, it was revealed that heredity plays a role in the development of society. Also, the longer the duration of menopause, the more pronounced the signs of metabolic diseases: obesity, increased cholesterol, triglycerides, lipoproteins, low decline and lipoproteins, very low decline, decreased lipoprotein levels, high probability, insulin, development of insulin resistance, vascular complications, diabetes mellitus.

Keywords: postmenopause, violation of protection against exposure, lipid metabolism, insulin resistance.

References:

1. Adasheva TV, Demicheva OYu. Metabolicheskiy sindrom. Osnovyi patogeneticheskoy terapii. Lech vrach 2010;(10):24-8. 2. Butrova SA. Metabolicheskiy sindrom: patogenez, klinika, diagnostika, podhodyi k lecheniyu. RMZh. 2011;9(2):56-61. 3. Duka YuM, Lomazova TYa. Printsipyi diagnostiki metabolicheskih narusheniy u zhenschin v postmenopauze. Zb. nauk. pr. Asots. akush.gInekol. Ukrayini. – K: 2009. 242-245 p. 4. Dismetabolichnih proyaviv u zhinok v perimenopauzi ta rannomu menopauzalnomu periodi na foni fibrozno-kistoznoyi mastopatiyi. Reproduktivna endokrinologIya. 2016;(4):82-6. 5. Kempbell S, Mong E. Ginekologiya ot desyati uchiteley. M: MIA; 2013. 328p. Lyubota RV, Zotov AS, Vereschako RI, Lyubota II. Metabolicheskiy sindrom i rak molochnoy zhelezyi: rukovodstvo dlya vrachey. Kiev: Zaslavskiy A.Yu.2016. 62p. 6. Natsionalniy konsensus schodo vedennya patsientok u klimakteriyi. Reproduktivnaya endokrinologiya. 2016;27(1):8-25. 7. Black DM, Steinbuch M, Palermo L. Anassessment toot for predicting fracture risk in postmenopausal women. Osteoporos Int.2011;(12):519-28. 8. Trigatti BL, Krieger M, Rigotti A. Influence of the HDL receptor SRB-1 on lipoprotein metabolism and atheroscle-rosis. Arterioscler Thromb VascBiol. 2003 Oct 1;23(10):1732-8.